PATENTSCOPE sera indisponible durant quelques heures pour des raisons de maintenance le lundi 03.02.2020 à 10:00 AM CET
Recherche dans les collections de brevets nationales et internationales
Une partie du contenu de cette demande n'est pas disponible pour le moment.
Si cette situation persiste, contactez-nous auObservations et contact
1. (WO2015173258) SOLUTION PHARMACEUTIQUE COMPRENANT DE LA DOPAMINE, DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT DE LA MALADIE DE PARKINSON



Avertissement La version image (PDF) disponible dans PATENTSCOPE est la version officielle. Cette version HTML en ligne est fournie pour aider les utilisateurs. Malgré le grand soin apporté à la compilation pour assurer une représentation précise et exacte des données figurant sur le document/les images imprimés, des erreurs et/ou des omissions ne peuvent pas être exclues en raison des processus de transmission et de conversion de données et des limitations inhérentes aux processus de traduction (éventuellement) automatique utilisés. Les liens hypertexte suivis de ce symbole sont associés à des ressources externes qui ne sont pas contrôlées par l'OMPI. L'OMPI décline toute responsabilité concernant les points mentionnés ci-dessus.

INTERNATIONAL SEARCH REPORT (ISR)
Part 1:  1  2  3  4  5  6          Part 2:  A  B  C  D  E 
International application No. Applicant's or agent's file reference
PCT/EP2015/060511 BCT150131INS
International filing date (day/month/year) (Earliest) Priority Date (day/month/year)
12 May 2015 13 May 2014
Applicant
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE...
FOR FURTHER ACTION: See Form PCT/ISA/220 as well as, where applicable, item 5 below.
This international search report has been prepared by this International Searching Authority and is transmitted to the applicant according to Article 18. A copy is being transmitted to the International Bureau.
It is also accompanied by a copy of each prior art document cited in this report.
1. Basis of the report
a. With regard to the language, the international search was carried out on the basis of:
the international application in the language in which it was filed.
a translation of the international application into                                          which is the language of a translation furnished for the purposes of international search (Rules 12.3(a) and 23.1(b)).
b.
This international search report has been established taking into account the rectification of an obvious mistake authorized by or notified to this Authority under Rule 91 (Rule 43.6bis(a)).
c.
With regard to any nucleotide and/or amino acid sequence disclosed in the international application, the international search was carried out on the basis of a sequence listing filed or furnished:
2. Certain claims were found unsearchable
3. Unity of invention is lacking
4. Title of the invention
The text is approved as submitted by the applicant.
The text has been established by this Authority to read as follows:
5. Abstract
The text is approved as submitted by the applicant.
The text has been established, according to Rule 38.2, by this Authority as it appears in Box No. IV. The applicant may, within one month from the date of mailing of this international search report, submit comments to this Authority.
6. Drawings
a.
The figure of the drawings to be published with the abstract is Figure No. ____________
as suggested by the applicant.
as selected by this Authority, because the applicant failed to suggest a figure.
as selected by this Authority, because this figure better characterizes the invention.
b.
none of the figures is to be published with the abstract.

A. CLASSIFICATION OF SUBJECT MATTER

     A61K 31/137 (2006.01)i; A61K 9/08 (2006.01)i; A61M 5/142 (2006.01)i; A61P 25/16 (2006.01)i; A61K 9/00 (2006.01)i
According to International Patent Classification (IPC) or to both national classification and IPC

B. FIELDS SEARCHED

Minimum documentation searched (classification system followed by classification symbols):
     A61K; A61M
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched:
Electronic data base consulted during the international search (name of data base and, where practicable, search terms used):
EPO-Internal, BIOSIS, CHEM ABS Data, EMBASE, WPI Data

C. DOCUMENTS CONSIDERED TO BE RELEVANT

Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
(1)
A
MX 2012012559 A (ARAGON PATRICIA VERGARA [MX]) 28 April 2014 (2014-04-28)
1-8
page 1, lines 4-8
page 11, lines 3-11
page 13, lines 29-30
page 16, lines 7-25
page 18, lines 20-26
page 20, lines 17-23
page 21, lines 7-10
claims 1-2
(2)
A
LEE SENDELBECK S ET AL, "Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion", 04 March 1985 (1985-03-04), Vol. 328, No. 2, page 251-258,
XP024272130
[retrieved on  1985-03-04]
1-8
page 251, right-hand column
page 252, left-hand column, last paragraph - page 253, left-hand column, paragraph 1
(3)
A
WO 03041687 A2 (AGUETTANT LAB [FR]; DINNEQUIN BERNARD [FR]) 22 May 2003 (2003-05-22)
1-8
page 5, paragraph 2
claims; examples 1,2,6,
(4)
A
DE YEBENES J G ET AL, "Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease", JOURNAL OF NEURAL TRANSMISSION. SUPPLEMENTUM, SPRINGER, AUSTRIA,Vol. 27, No. Suppl, 01 January 1988 (1988-01-01), page 141-160,
XP008174001
1-8
abstract
page 143, last paragraph - page 144, paragraph 1
page 146, paragraph 4
page 154, last paragraph - page 156, paragraph 1
page 158, paragraph 1-2
(5)
DATABASE WPI Thomson Scientific, London, GB; 27 March 2008 (2008-03-27), Vol. 2008, No. 35, AN 2008-F134660
XP002734214
A
& JP 2008068122  A  (KYOWA HAKKO KOGYO KK) 27 March 2008 (2008-03-27)
1-8
abstract
paragraphs [0001], [0002], [0004], [0006], [0014]; claims
*
Special categories of cited documents:
"A"
document defining the general state of the art which is not considered to be of particular relevance
"E"
earlier application or patent but published on or after the international filing date
"L"
document which may throw doubts on priority claim(s) or which is cited to establish the publication date of another citation or other special reason (as specified)
"O"
document referring to an oral disclosure, use, exhibition or other means
"P"
document published prior to the international filing date but later than the priority date claimed
"T"
later document published after the international filing date or priority date and not in conflict with the application but cited to understand the principle or theory underlying the invention
"X"
document of particular relevance; the claimed invention cannot be considered novel or cannot be considered to involve an inventive step when the document is taken alone
"Y"
document of particular relevance; the claimed invention cannot be considered to involve an inventive step when the document is combined with one or more other such documents, such combination being obvious to a person skilled in the art
"&"
document member of the same patent family

D. INFORMATION ON PATENT FAMILY MEMBERS

Patent document cited in search report Publication date
(day/month/year)
Patent family member(s) Publication date
(day/month/year)
MX 2012012559 A
28 April 2014
-----------------------------------------------------------------------
WO 03041687 A2
22 May 2003
EP 1443902 A2
FR 2832063 A1
US 2005070613 A1
WO 03041687 A2
11 August 2004
16 May 2003
31 March 2005
22 May 2003
JP 2008068122 A
27 March 2008
NONE
Name and mailing address of the ISA/:
European Patent Office
P.B. 5818, Patentlaan 2, 2280 HV Rijswijk,
Netherlands
Telephone No. (+31-70)340-2040
Facsimile No. (+31-70)340-3016
Date of the actual completion of the international search:
16 July 2015
Date of mailing of the international search report:
03 August 2015
Authorized officer:
Gradassi, Giulia
Top    Part 1: 1 2 3 4 5 6         Part 2: A B C D E